Published on: June 2, 2026
Take an exclusive look at emerging cardiovascular innovation from the 2025 HeartX cohort, MedAxiom and HealthTech Arkansas’s accelerator focused on supporting early-stage companies advancing cardiovascular care.
This session featured:
CathVision highlighted its ECGenius system, which delivered high-fidelity, noise-cancelling cardiac signals to support ablation decisions. Its technology also provided real-time tissue feedback during pulsed field ablation and identified focal AFib drivers to help guide more precise interventions.
FibriCheck showcased its FDA-cleared platform for remote AFib detection and monitoring, using smartphone-based assessments and AI-powered reporting to support clinical workflows, informed decision-making, and expanded access to at-home rhythm monitoring.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.